NUT midline carcinoma (NMC) is a rare and aggressive cancer, with survival typically less
than seven months, that can arise in people of any age. Genetically, NMC is defined by the …

Nuclear protein in testis (NUT)-midline carcinoma (NMC) is a rare, aggressive disease
typically presenting with a single t (15; 19) translocation that results in the generation of a …

Purpose: NUT midline carcinoma (NMC) is a poorly differentiated squamous cancer
characterized by rearrangement of the NUT gene. Research advances have provided …

NUT midline carcinoma (NMC) is a rare, aggressive poorly differentiated carcinoma
genetically defined by NUTM1 gene rearrangement. The purpose of this study was to …

NUT carcinoma (NC) is a rare and highly aggressive malignancy with a dismal prognosis
and a median survival of 6–9 months only. Although very few cases of NC are reported each …

NMC is a recently recognized cancer type hallmarked by chromosomal translocation
involving the NUT gene, a catastrophic event leading to fusion oncoprotein responsible for …

NUT carcinoma is a rare, aggressive cancer defined by rearrangements of the NUTM1 gene.
No routinely effective treatments of NUT carcinoma exist, despite harboring a targetable …

6085 Background: NUT midline carcinoma (NMC) is a rare subtype of squamous cancer
defined by rearrangement of the NUT gene. Due to its rarity and under-diagnosis, there are …

NUT midline carcinoma (NMC) is a rare, aggressive human cancer, genetically defined by
rearrangements of the gene NUT (HUGO symbol: C15orf55). In the majority (∼ 75%) of …

Introduction NUT midline carcinoma (NMC) is a rare and aggressive epithelial cancer
arising from median organs. It is driven by chromosomal translocation t (15; 19) involving the …